ASSAY METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PAROXETINE AND CLONAZEPAM BY RP- HPLC

Journal Title: Int J of Pharm Res & Analy - Year 2014, Vol 4, Issue 8

Abstract

A simple, precise, rapid, specific and accurate reverse phase high performance liquid chromatography method was developed for simultaneous estimation of Paroxetine and Clonazepam in pharmaceutical dosage form. Chromatographic separation was performed on Agilent Eclipse XDB (C8) (4.6mm x 150mm, 5m) column, with mobile phase comprising of mixture of buffer (pH7, adjusted with ammonium acetate), acetonitrile in the ratio of 82:18v/v, at the flow rate 0.8 ml/min. The detection was carried out at 265 nm. The retention times of paroxetine and clonazepam were found to be 2.36 and 3.14 mins respectively with a run time of 5 mins, theoretical levels for paroxetine and clonazepam were 6753 and 4693 respectively, with a resolution of 5.10. As per ICH guidelines the method was validated for linearity, accuracy, precision, limit of detection and limit of quantitation, robustness and ruggedness. Linearity of paroxetine was found in the range of 100-300μg/mL and that for clonazepam was found to be 2-6 μg/mL.

Authors and Affiliations

Bhagyasree T* , Neelam I , Ajitha A , Uma Maheshwara Rao V

Keywords

Related Articles

 A STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF VALSARTAN AND ATORVASTATIN FROM THEIR COMBINATION DRUG PRODUCT

simple, precise and accurate stability indicating RP-HPLC method has been developed and subsequently validated for simultaneous estimation of Valsartan and Atorvastatin from their combination dosage form. Water’s HPLC e...

VARIATIONS OF LIPOPROTEINS IN PATIENTS OF CHRONIC RENAL DISEASES

The present study is concerned with the determination of HDL & LDL (Lipoproteins) in the serum of patients with chronic renal disease. Fifty (50) patients with chronic renal disease and fifty (50) healthy controls we...

 DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR CEFTIBUTEN IN BULK AND ITS PHARMACEUTICAL DOSAGE FORM

 A simple, precise, rapid and accurate reverse phase HPLC method has been developed for the determination of Ceftibuten in bulk and its pharmaceutical dosage form. An enable C18G, 250mmX4.6mm i.d, 5μm particle size...

 NANOFIBERS - A NEW TREND IN NA

 Polymer nanofibers, with diameters in the nanometer range, possess larger surface areas per unit mass and permit easier addition of surface functionalities compared with polymer microfibers. Hence, polymer nanofibe...

 MICROSPONGES: A NOVEL DRUG DELIVERY SYSTEM FOR CONTROLLED DELIVERY OF TOPICAL DRUGS

 Even though possess several advantages topical formulations have some drawbacks such as the need to contain high concentrations of active agents for effective therapy due to the low efficiency of delivery system, r...

Download PDF file
  • EP ID EP106590
  • DOI -
  • Views 119
  • Downloads 0

How To Cite

Bhagyasree T*, Neelam I, Ajitha A, Uma Maheshwara Rao V (2014). ASSAY METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PAROXETINE AND CLONAZEPAM BY RP- HPLC. Int J of Pharm Res & Analy, 4(8), 421-427. https://europub.co.uk/articles/-A-106590